Symphony Financial, Ltd. Co.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1800687
HOUSTON, TX
Position in REGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$312,146
+$74,411 QoQ
Shares Held
404
+31.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Symphony Financial, Ltd. Co. holds $619,760 across 3 Biotechnology names.
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $312,146 | 404 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $237,735 | 308 | Shares | Sole | 2026-02-11 | |
| 2020-06-30 | $405,372 | 650 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $222,660 | 456 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||